Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000713933 | SCV000243704 | likely benign | not provided | 2020-03-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087398 | SCV000544306 | benign | Tuberous sclerosis 2 | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000491452 | SCV000579616 | benign | Hereditary cancer-predisposing syndrome | 2018-08-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics Inc | RCV000713933 | SCV000844580 | uncertain significance | not provided | 2018-08-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001087398 | SCV002039838 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000491452 | SCV002533515 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-22 | criteria provided, single submitter | curation | |
Ce |
RCV000713933 | SCV004010429 | uncertain significance | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing |